EN
TR
The place of age and hematological parameters in hospitalization of pediatric COVID-19 patients
Öz
Objective: To examined the relationship between hematologic parameters and prognosis in patients diagnosed with COVID-19 in the pediatric emergency department.
Methods: This study was designed as a retrospective cross-sectional study. A total of 605 patients admitted to the emergency department were analyzed. WBC, lymphocyte, monocyte, neutrophil and platelet counts, hemoglobin, creatinine, albumin and CRP levels were recorded. Neutrophil-lymphocyte ratio (NLR), SII (platelet count × neutrophil count/lymphocyte count), lymphocyte-CRP ratio (LCR), platelet-NLR (P/NLR) and platelet-CRP ratio (P/CRP) were obtained. Cases were classified according to hospitalization status and age groups.
Results: A total of 656 pediatric patients were admitted to a tertiary hospital emergency department with COVID-19 rt-PCR positivity.51 patients were excluded. 225 (37.2%) of the patients were hospitalized patients.80.00% of patients under 1 year were hospitalized, whereas 26.9% of the 15-17 age group were hospitalized. WBC levels were significantly higher in hospitalized patients only in the 7-14 age group (p=0.007); lymphocyte and CRP levels were not observed to be significant in terms of hospitalization in any age group.
Conclusion: In pediatric patients infected with Covid-19, hospitalization of younger patients was prioritized over all hematologic parameters due to the uncertainty of the process and prognosis at the beginning.
Anahtar Kelimeler
Kaynakça
- 1. Mallapaty S. How do children spread the coronavirus? the science still isn't clear. Nature 2020;581(7807):127e8. https://doi.org/10.1038/d41586-020- 01354-0
- 2. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of covid-19 in 391 cases and 1286 of their close contacts in shenzhen, China: a retrospective cohort study. Lancet Infect Dis 2020. https://doi.org/10.1016/S1473-3099(20)30287-5.
- 3. Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J,et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr Respir Rev. 2021 Jun;38:51-57. doi: 10.1016/j.prrv.2020.08.001.
- 4. Curbelo J, Luquero Bueno S, Galván-Román JM, Ortega-Gómez M, Rajas O, FernándezJiménez G, et al. Inflammation biomarkers in blood as mortality predictors in communityacquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio. PLoS One. 2017 Mar 16;12(3):e0173947. doi: 10.1371/journal.pone.0173947. Erratum in: PLoS One. 2019 Feb 22;14(2):e0212915.
- 5. Peng J, Qi D, Yuan G, Deng X, Mei Y, Feng L, et al. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, crosssectional study. J Clin Lab Anal. 2020 Oct;34(10):e23475. doi: 10.1002/jcla.23475.
- 6. Guner Ozenen G, Sahbudak Bal Z, Umit Z, Bilen NM, Yildirim Arslan S, Yurtseven A, el al. Demographic, clinical, and laboratory features of COVID-19 in children: The role of mean platelet volume in predicting hospitalization and severity. J Med Virol. 2021 May;93(5):3227- 3237. doi: 10.1002/jmv.26902.
- 7. Alkan G, Sert A, Emiroglu M, Tuter Oz SK, Vatansev H. Evaluation of hematological parameters and inflammatory markers in children with COVID-19. Ir J Med Sci. 2022 Aug;191(4):1725-1733. doi: 10.1007/s11845- 021-02762-5.
- 8. Milenkovic J, Djindjic B, Djordjevic B, Stojiljkovic V, Stojanovic D, Petrovic S, et al. Platelet-derived immuno inflammatory indices show best performance in early prediction of COVID-19 progression. J Clin Lab Anal. 2022 Sep;36(9):e24652. doi: 10.1002/jcla.24652.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Çocuk Bulaşıcı Hastalıkları
Bölüm
Klinik Araştırma
Erken Görünüm Tarihi
7 Kasım 2025
Yayımlanma Tarihi
10 Ekim 2025
Gönderilme Tarihi
15 Ekim 2024
Kabul Tarihi
21 Şubat 2025
Yayımlandığı Sayı
Yıl 2025 Cilt: 6 Sayı: 3
APA
Metin, H., Köremezli Keskin, N., & Şen, A. (2025). The place of age and hematological parameters in hospitalization of pediatric COVID-19 patients. Experimental and Applied Medical Science, 6(3), 231-240. https://doi.org/10.46871/eams.1566988
AMA
1.Metin H, Köremezli Keskin N, Şen A. The place of age and hematological parameters in hospitalization of pediatric COVID-19 patients. Experimental and Applied Medical Science. 2025;6(3):231-240. doi:10.46871/eams.1566988
Chicago
Metin, Hamdi, Nevin Köremezli Keskin, ve Adilen Şen. 2025. “The place of age and hematological parameters in hospitalization of pediatric COVID-19 patients”. Experimental and Applied Medical Science 6 (3): 231-40. https://doi.org/10.46871/eams.1566988.
EndNote
Metin H, Köremezli Keskin N, Şen A (01 Ekim 2025) The place of age and hematological parameters in hospitalization of pediatric COVID-19 patients. Experimental and Applied Medical Science 6 3 231–240.
IEEE
[1]H. Metin, N. Köremezli Keskin, ve A. Şen, “The place of age and hematological parameters in hospitalization of pediatric COVID-19 patients”, Experimental and Applied Medical Science, c. 6, sy 3, ss. 231–240, Eki. 2025, doi: 10.46871/eams.1566988.
ISNAD
Metin, Hamdi - Köremezli Keskin, Nevin - Şen, Adilen. “The place of age and hematological parameters in hospitalization of pediatric COVID-19 patients”. Experimental and Applied Medical Science 6/3 (01 Ekim 2025): 231-240. https://doi.org/10.46871/eams.1566988.
JAMA
1.Metin H, Köremezli Keskin N, Şen A. The place of age and hematological parameters in hospitalization of pediatric COVID-19 patients. Experimental and Applied Medical Science. 2025;6:231–240.
MLA
Metin, Hamdi, vd. “The place of age and hematological parameters in hospitalization of pediatric COVID-19 patients”. Experimental and Applied Medical Science, c. 6, sy 3, Ekim 2025, ss. 231-40, doi:10.46871/eams.1566988.
Vancouver
1.Hamdi Metin, Nevin Köremezli Keskin, Adilen Şen. The place of age and hematological parameters in hospitalization of pediatric COVID-19 patients. Experimental and Applied Medical Science. 01 Ekim 2025;6(3):231-40. doi:10.46871/eams.1566988